Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.

Leung SCY, Nielsen TO, Zabaglo LA, Arun I, Badve SS, Bane AL, Bartlett JMS, Borgquist S, Chang MC, Dodson A, Ehinger A, Fineberg S, Focke CM, Gao D, Gown AM, Gutierrez C, Hugh JC, Kos Z, Laenkholm AV, Mastropasqua MG, Moriya T, Nofech-Mozes S, Osborne CK, Penault-Llorca FM, Piper T, Sakatani T, Salgado R, Starczynski J, Sugie T, van der Vegt B, Viale G, Hayes DF, McShane LM, Dowsett M; International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group (BIG-NABCG).

Histopathology. 2019 Apr 24. doi: 10.1111/his.13880. [Epub ahead of print]

PMID:
31017314
2.

Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration.

Leung SCY, Nielsen TO, Zabaglo L, Arun I, Badve SS, Bane AL, Bartlett JMS, Borgquist S, Chang MC, Dodson A, Enos RA, Fineberg S, Focke CM, Gao D, Gown AM, Grabau D, Gutierrez C, Hugh JC, Kos Z, Lænkholm AV, Lin MG, Mastropasqua MG, Moriya T, Nofech-Mozes S, Osborne CK, Penault-Llorca FM, Piper T, Sakatani T, Salgado R, Starczynski J, Viale G, Hayes DF, McShane LM, Dowsett M.

NPJ Breast Cancer. 2016 May 18;2:16014. doi: 10.1038/npjbcancer.2016.14. eCollection 2016.

3.

An international Ki67 reproducibility study.

Polley MY, Leung SC, McShane LM, Gao D, Hugh JC, Mastropasqua MG, Viale G, Zabaglo LA, Penault-Llorca F, Bartlett JM, Gown AM, Symmans WF, Piper T, Mehl E, Enos RA, Hayes DF, Dowsett M, Nielsen TO; International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group.

J Natl Cancer Inst. 2013 Dec 18;105(24):1897-906. doi: 10.1093/jnci/djt306. Epub 2013 Nov 7.

4.

An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.

Rimm DL, Leung SCY, McShane LM, Bai Y, Bane AL, Bartlett JMS, Bayani J, Chang MC, Dean M, Denkert C, Enwere EK, Galderisi C, Gholap A, Hugh JC, Jadhav A, Kornaga EN, Laurinavicius A, Levenson R, Lima J, Miller K, Pantanowitz L, Piper T, Ruan J, Srinivasan M, Virk S, Wu Y, Yang H, Hayes DF, Nielsen TO, Dowsett M.

Mod Pathol. 2019 Jan;32(1):59-69. doi: 10.1038/s41379-018-0109-4. Epub 2018 Aug 24.

PMID:
30143750
5.

An interobserver reproducibility analysis of Ki67 visual assessment in breast cancer.

Shui R, Yu B, Bi R, Yang F, Yang W.

PLoS One. 2015 May 1;10(5):e0125131. doi: 10.1371/journal.pone.0125131. eCollection 2015.

6.

Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study.

Mikami Y, Ueno T, Yoshimura K, Tsuda H, Kurosumi M, Masuda S, Horii R, Toi M, Sasano H.

Cancer Sci. 2013 Nov;104(11):1539-43. doi: 10.1111/cas.12245. Epub 2013 Sep 6.

7.

An international study to increase concordance in Ki67 scoring.

Polley MY, Leung SC, Gao D, Mastropasqua MG, Zabaglo LA, Bartlett JM, McShane LM, Enos RA, Badve SS, Bane AL, Borgquist S, Fineberg S, Lin MG, Gown AM, Grabau D, Gutierrez C, Hugh JC, Moriya T, Ohi Y, Osborne CK, Penault-Llorca FM, Piper T, Porter PL, Sakatani T, Salgado R, Starczynski J, Lænkholm AV, Viale G, Dowsett M, Hayes DF, Nielsen TO.

Mod Pathol. 2015 Jun;28(6):778-86. doi: 10.1038/modpathol.2015.38. Epub 2015 Feb 20.

8.

Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.

Abubakar M, Orr N, Daley F, Coulson P, Ali HR, Blows F, Benitez J, Milne R, Brenner H, Stegmaier C, Mannermaa A, Chang-Claude J, Rudolph A, Sinn P, Couch FJ, Devilee P, Tollenaar RA, Seynaeve C, Figueroa J, Sherman ME, Lissowska J, Hewitt S, Eccles D, Hooning MJ, Hollestelle A, Martens JW, van Deurzen CH, Investigators K, Bolla MK, Wang Q, Jones M, Schoemaker M, Wesseling J, van Leeuwen FE, Van 't Veer L, Easton D, Swerdlow AJ, Dowsett M, Pharoah PD, Schmidt MK, Garcia-Closas M.

Breast Cancer Res. 2016 Oct 18;18(1):104.

9.

Interobserver Variability of Ki-67 Measurement in Breast Cancer.

Chung YR, Jang MH, Park SY, Gong G, Jung WH; Korean Breast Pathology Ki-67 Study Group.

J Pathol Transl Med. 2016 Mar;50(2):129-37. doi: 10.4132/jptm.2015.12.24. Epub 2016 Feb 15.

10.

A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.

Zhong F, Bi R, Yu B, Yang F, Yang W, Shui R.

PLoS One. 2016 Feb 29;11(2):e0150505. doi: 10.1371/journal.pone.0150505. eCollection 2016.

11.

Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.

Koopman T, Buikema HJ, Hollema H, de Bock GH, van der Vegt B.

Breast Cancer Res Treat. 2018 May;169(1):33-42. doi: 10.1007/s10549-018-4669-2. Epub 2018 Jan 18.

12.

Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility.

Hida AI, Bando K, Sugita A, Maeda T, Ueda N, Matsukage S, Nakanishi M, Kito K, Miyazaki T, Ohtsuki Y, Oshiro Y, Inoue H, Kawaguchi H, Yamashita N, Aogi K, Moriya T.

J Clin Pathol. 2015 May;68(5):356-61. doi: 10.1136/jclinpath-2014-202695. Epub 2015 Feb 11.

PMID:
25673730
13.

Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study.

Acs B, Pelekanou V, Bai Y, Martinez-Morilla S, Toki M, Leung SCY, Nielsen TO, Rimm DL.

Lab Invest. 2019 Jan;99(1):107-117. doi: 10.1038/s41374-018-0123-7. Epub 2018 Sep 4.

PMID:
30181553
14.

A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.

Laurinavicius A, Plancoulaine B, Laurinaviciene A, Herlin P, Meskauskas R, Baltrusaityte I, Besusparis J, Dasevicius D, Elie N, Iqbal Y, Bor C.

Breast Cancer Res. 2014;16(2):R35.

15.

Intratumoral heterogeneity of Ki67 expression in early breast cancers exceeds variability between individual tumours.

Focke CM, Decker T, van Diest PJ.

Histopathology. 2016 Nov;69(5):849-861. doi: 10.1111/his.13007. Epub 2016 Jul 26.

PMID:
27270560
16.

Visual assessment of Ki67 at a glance is an easy method to exclude many luminal-type breast cancers from counting 1000 cells.

Hida AI, Oshiro Y, Inoue H, Kawaguchi H, Yamashita N, Moriya T.

Breast Cancer. 2015 Mar;22(2):129-34. doi: 10.1007/s12282-013-0460-8. Epub 2013 Mar 31.

PMID:
23543399
17.

Interlaboratory variability of Ki67 staining in breast cancer.

Focke CM, Bürger H, van Diest PJ, Finsterbusch K, Gläser D, Korsching E, Decker T; German Breast Screening Pathology Initiative.

Eur J Cancer. 2017 Oct;84:219-227. doi: 10.1016/j.ejca.2017.07.041. Epub 2017 Aug 19.

PMID:
28829990
18.
19.

Comparison between Ki67 labeling index determined using image analysis software with virtual slide system and that determined visually in breast cancer.

Maeda I, Abe K, Koizumi H, Nakajima C, Tajima S, Aoki H, Tsuchiya J, Tsuchiya S, Tsuchiya K, Shimo A, Tsugawa K, Ueno T, Tatsunami S, Takagi M.

Breast Cancer. 2016 Sep;23(5):745-51. doi: 10.1007/s12282-015-0634-7. Epub 2015 Aug 14.

PMID:
26271611
20.

Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer.

Aleskandarany MA, Green AR, Ashankyty I, Elmouna A, Diez-Rodriguez M, Nolan CC, Ellis IO, Rakha EA.

Breast Cancer Res Treat. 2016 Jul;158(2):287-95. doi: 10.1007/s10549-016-3893-x. Epub 2016 Jul 5.

PMID:
27380874

Supplemental Content

Support Center